Clinical Trial Update: Oxaliplatin in Treating Patients With Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing oxaliplatin used for metastatic bladder cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Chicago | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED